EpiFrontier Therapeutics | RoundOS

Weekly digest by email

Loading companies…

EpiFrontier Therapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Mar 24, 2026	Grant	$32M	Japan Agency for Medical Research and Development (AMED) — Role not disclosed

Investors

Japan Agency for Medical Research and Development (AMED)Grant

Coverage

Mar 24, 2026EpiFrontier Therapeutics · Grant

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

epifrontier.com ↗